Replies to post #30311 on Propanc Biopharma Inc (PPCB)

[brando5]

Lots brewing here phenomenol trial results! This company actually has a cancer tumor reducing drug that reversed tumor growth over 80% so far in pancreas which has no real effective treatment. This pancreatic market alone is 9 billion dollars and were looking at possibly the most effective and top treatment potential. Nothing else shows effectiveness like this. Definitely a biotech gem and very cheap price! News can definitely blast this off and send value soring. This can be used compassionately and is an orphan drug status fast-track company with these results for such a limited treatment illness. This dips then bounces back at these levels. It could easily be a 100 million plus market cap company as developments progress. The tumor shrinkage in pancreatic and ovarian cancer cells is phenomenol. Very impressive and shocking effectiveness not many companies can show for even billion dollar companies. Long-term value should increase this is a gem with lots brewing. Excellent price. Great company that values its shareholders and stock value as well. Lots to come and low market cap. http://wealthyventurecapitalist.com/2015/12/14/the-only-bit-of-good-news-from-2015/

[Inorout]

It never makes sense to buy or hold shares in pump and dump like PPCH. The promotors will likely pump it again of course but so what... you want to use pumps to sell if you have shares. It doesn't change the fact that the cancer cure compound that PPCH is pumping comes from Julian Kenyon, PPCH's "chief scientist". Everybody needs to Google Julian Kenyon. He's been in lots of trouble with British medical authorities for false cancer cure claims, conning terminally ill cancer patients for cancer treatments that were false. Is it possible to get any lower than lying to dying cancer patents for profit by selling false hope to desperate dying cancer patients? So if you're holding PPCH, you're betting your money on Julian Kenyon.